Who
Christian Klemt
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, uniQure.
In numbers
- Trades disclosed
- 72
- Buys
- 0
- Sells
- 30
- Bought
- $0
- Sold
- $5.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Dec 2017
- Last trade
- 4 Mar 2026
- Last filed
- 6 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 6 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Code A | —39,600 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $109K12,000 at $9.06 | filing |
| 4 Mar 2026filed 6 Mar 2026 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,900 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,900 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Code A | —39,600 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $109K12,000 at $9.06 | filing |
| 2 Mar 2026filed 4 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $125K12,532 at $9.95 | filing |
| 2 Mar 2026filed 4 Mar 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $125K12,532 at $9.95 | filing |
| 25 Feb 2026filed 27 Feb 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $148K6,217 at $23.86 | filing |
| 25 Feb 2026filed 27 Feb 2026 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $148K6,217 at $23.86 | filing |
| 26 Sep 2025filed 26 Sep 2025 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 26 Sep 2025filed 26 Sep 2025 | QURE uniQureBiotechnology | SEC FORM 4 Code M | $81K15,000 at $5.37 | filing |
| 26 Sep 2025filed 26 Sep 2025 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $825K15,000 at $55.00 | filing |
| 24 Sep 2025filed 26 Sep 2025 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 24 Sep 2025filed 26 Sep 2025 | QURE uniQureBiotechnology | SEC FORM 4 Code M | $39K3,000 at $13.03 | filing |
| 24 Sep 2025filed 26 Sep 2025 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $120K3,000 at $40.04 | filing |
| 4 Mar 2025filed 5 Mar 2025 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $107K10,438 at $10.29 | filing |
| 3 Mar 2025filed 5 Mar 2025 | QURE uniQureoption or derivative · Biotechnology | SEC FORM 4 Code A | —126,000 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | QURE uniQureBiotechnology | SEC FORM 4 Code A | —73,000 at $0.00 | filing |
| 27 Feb 2025filed 27 Feb 2025 | QURE uniQureBiotechnology | SEC FORM 4 Sold | $33K2,916 at $11.32 | filing |
News
Reviewing Alkermes (NASDAQ:ALKS) and uniQure (NASDAQ:QURE)QURE · tickerreport.com · 13 Oct 2026Vir Biotechnology (NASDAQ:VIR) vs. uniQure (NASDAQ:QURE) Critical ContrastQURE · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Christian Klemt; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.